Copy to clipboard 
Medartis appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. He succeeds Christoph Brönnimann, who will ensure a seamless transition.
Schupp has held various senior leadership roles in Europe and Latin America at Straumann Group over the last 17 years. During his tenure at Straumann, he demonstrated a strong ability to perform and transform. In 2014, he assumed the post of SVP of LATAM at Straumann and in 2015 he also became CEO of Neodent, steering the LATAM region through ten years of significant growth. He was appointed to the Executive Management Board of Straumann in 2016.
Schupp began his career in 1986 with Merck KGaA and rose through country management to the position of Regional Manager Latin America and USA. He moved to Wella in 2000 as Managing Director of the business in Russia and became Managing Director Professional Care Portugal in 2004, following the acquisition of Wella by P&G.
Marco Gadola, Chairman of Medartis, said, “Matthias is an exceptionally talented and dynamic leader with a track record of delivery, driving growth and developing winning teams. He brings with him deep expertise in medical technology as well as strong experience in both developed and developing markets. I’d like to thank Christoph Brönnimann for his years of great service and for continuing to lead Medartis until Matthias joins us later this year, and wish him all the best on his next journey.”
By ORTHOWORLD estimates, Medartis is among the top 10 orthopedic companies posting revenue in the trauma segment. For FY23, the company recorded US $195.1 million in revenue for the segment, up 13.6% vs. FY22.
Source: Medartis
Medartis appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. He succeeds Christoph Brönnimann, who will ensure a seamless transition.
Schupp has held various senior leadership roles in Europe and Latin America at Straumann Group over the last 17 years. During his tenure at Straumann, he demonstrated...
Medartis appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. He succeeds Christoph Brönnimann, who will ensure a seamless transition.
Schupp has held various senior leadership roles in Europe and Latin America at Straumann Group over the last 17 years. During his tenure at Straumann, he demonstrated a strong ability to perform and transform. In 2014, he assumed the post of SVP of LATAM at Straumann and in 2015 he also became CEO of Neodent, steering the LATAM region through ten years of significant growth. He was appointed to the Executive Management Board of Straumann in 2016.
Schupp began his career in 1986 with Merck KGaA and rose through country management to the position of Regional Manager Latin America and USA. He moved to Wella in 2000 as Managing Director of the business in Russia and became Managing Director Professional Care Portugal in 2004, following the acquisition of Wella by P&G.
Marco Gadola, Chairman of Medartis, said, “Matthias is an exceptionally talented and dynamic leader with a track record of delivery, driving growth and developing winning teams. He brings with him deep expertise in medical technology as well as strong experience in both developed and developing markets. I’d like to thank Christoph Brönnimann for his years of great service and for continuing to lead Medartis until Matthias joins us later this year, and wish him all the best on his next journey.”
By ORTHOWORLD estimates, Medartis is among the top 10 orthopedic companies posting revenue in the trauma segment. For FY23, the company recorded US $195.1 million in revenue for the segment, up 13.6% vs. FY22.
Source: Medartis
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
